CD93 (Portuguese Wikipedia)
Analysis of information sources in references of the Wikipedia article "CD93" in Portuguese language version.
doi.org (Global: 2nd place; Portuguese: 4th place)
dx.doi.org
- Nepomuceno RR, Henschen-Edman AH, Burgess WH, Tenner AJ (fevereiro 1997). «cDNA cloning and primary structure analysis of C1qR(P), the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro». Immunity. 6 (2): 119–29. PMID 9047234. doi:10.1016/S1074-7613(00)80419-7
- Webster SD, Park M, Fonseca MI, Tenner AJ (janeiro 2000). «Structural and functional evidence for microglial expression of C1qR(P), the C1q receptor that enhances phagocytosis». Journal of Leukocyte Biology. 67 (1): 109–16. PMID 10648005. doi:10.1002/jlb.67.1.109
- Khan KA, McMurray J, Mohammed FM, Bicknell R (2019). «C-type lectin domain group 14 proteins in vascular biology, cancer and inflammation.». FEBS Journal. 286 (17): 3299–3332. PMC 6852297. PMID 31287944. doi:10.1111/febs.14985
- Mura M, Swain RK, Zhuang X, Vorschmitt H, Reynolds G, Durant S, Beesley JF, Herbert JM, Sheldon H, Andre M, Sanderson S, Glen K, Luu NT, McGettrick HM, Antczak P, Falciani F, Nash GB, Nagy ZS, Bicknell R (janeiro 2012). «Identification and angiogenic role of the novel tumor endothelial marker CLEC14A». Oncogene. 31 (3): 293–305. PMID 21706054. doi:10.1038/onc.2011.233
- Zekavat G, Mozaffari R, Arias VJ, Rostami SY, Badkerhanian A, Tenner AJ, Nichols KE, Naji A, Noorchashm H (junho 2010). «A novel CD93 polymorphism in non-obese diabetic (NOD) and NZB/W F1 mice is linked to a CD4+ iNKT cell deficient state». Immunogenetics. 62 (6): 397–407. PMC 2875467. PMID 20387063. doi:10.1007/s00251-010-0442-3
- McGreal EP, Ikewaki N, Akatsu H, Morgan BP, Gasque P (maio 2002). «Human C1qRp is identical with CD93 and the mNI-11 antigen but does not bind C1q». Journal of Immunology. 168 (10): 5222–32. PMID 11994479. doi:10.4049/jimmunol.168.10.5222
- Dieterich LC, Mellberg S, Langenkamp E, Zhang L, Zieba A, Salomäki H, Teichert M, Huang H, Edqvist PH, Kraus T, Augustin HG, Olofsson T, Larsson E, Söderberg O, Molema G, Pontén F, Georgii-Hemming P, Alafuzoff I, Dimberg A (novembro 2012). «Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGFβ2 in vascular abnormalization». The Journal of Pathology. 228 (3): 378–90. PMID 22786655. doi:10.1002/path.4072
- Langenkamp E, Zhang L, Lugano R, Huang H, Elhassan TE, Georganaki M, Bazzar W, Lööf J, Trendelenburg G, Essand M, Pontén F, Smits A, Dimberg A (novembro 2015). «Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival». Cancer Research. 75 (21): 4504–16. PMID 26363010. doi:10.1158/0008-5472.CAN-14-3636
- Lugano R, Vemuri K, Yu D, Bergqvist M, Smits A, Essand M, Johansson S, Dejana E, Dimberg A (agosto 2018). «CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis». The Journal of Clinical Investigation. 128 (8): 3280–3297. PMC 6063507. PMID 29763414. doi:10.1172/JCI97459
nih.gov (Global: 4th place; Portuguese: 8th place)
ncbi.nlm.nih.gov
- Nepomuceno RR, Henschen-Edman AH, Burgess WH, Tenner AJ (fevereiro 1997). «cDNA cloning and primary structure analysis of C1qR(P), the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro». Immunity. 6 (2): 119–29. PMID 9047234. doi:10.1016/S1074-7613(00)80419-7
- Webster SD, Park M, Fonseca MI, Tenner AJ (janeiro 2000). «Structural and functional evidence for microglial expression of C1qR(P), the C1q receptor that enhances phagocytosis». Journal of Leukocyte Biology. 67 (1): 109–16. PMID 10648005. doi:10.1002/jlb.67.1.109
- «Entrez Gene: CD93 CD93 molecule»
- Khan KA, McMurray J, Mohammed FM, Bicknell R (2019). «C-type lectin domain group 14 proteins in vascular biology, cancer and inflammation.». FEBS Journal. 286 (17): 3299–3332. PMC 6852297. PMID 31287944. doi:10.1111/febs.14985
- Mura M, Swain RK, Zhuang X, Vorschmitt H, Reynolds G, Durant S, Beesley JF, Herbert JM, Sheldon H, Andre M, Sanderson S, Glen K, Luu NT, McGettrick HM, Antczak P, Falciani F, Nash GB, Nagy ZS, Bicknell R (janeiro 2012). «Identification and angiogenic role of the novel tumor endothelial marker CLEC14A». Oncogene. 31 (3): 293–305. PMID 21706054. doi:10.1038/onc.2011.233
- McKearn JP, Baum C, Davie JM (janeiro 1984). «Cell surface antigens expressed by subsets of pre-B cells and B cells». Journal of Immunology. 132 (1): 332–9. PMID 6606670
- Zekavat G, Mozaffari R, Arias VJ, Rostami SY, Badkerhanian A, Tenner AJ, Nichols KE, Naji A, Noorchashm H (junho 2010). «A novel CD93 polymorphism in non-obese diabetic (NOD) and NZB/W F1 mice is linked to a CD4+ iNKT cell deficient state». Immunogenetics. 62 (6): 397–407. PMC 2875467. PMID 20387063. doi:10.1007/s00251-010-0442-3
- McGreal EP, Ikewaki N, Akatsu H, Morgan BP, Gasque P (maio 2002). «Human C1qRp is identical with CD93 and the mNI-11 antigen but does not bind C1q». Journal of Immunology. 168 (10): 5222–32. PMID 11994479. doi:10.4049/jimmunol.168.10.5222
- Dieterich LC, Mellberg S, Langenkamp E, Zhang L, Zieba A, Salomäki H, Teichert M, Huang H, Edqvist PH, Kraus T, Augustin HG, Olofsson T, Larsson E, Söderberg O, Molema G, Pontén F, Georgii-Hemming P, Alafuzoff I, Dimberg A (novembro 2012). «Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGFβ2 in vascular abnormalization». The Journal of Pathology. 228 (3): 378–90. PMID 22786655. doi:10.1002/path.4072
- Langenkamp E, Zhang L, Lugano R, Huang H, Elhassan TE, Georganaki M, Bazzar W, Lööf J, Trendelenburg G, Essand M, Pontén F, Smits A, Dimberg A (novembro 2015). «Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival». Cancer Research. 75 (21): 4504–16. PMID 26363010. doi:10.1158/0008-5472.CAN-14-3636
- Lugano R, Vemuri K, Yu D, Bergqvist M, Smits A, Essand M, Johansson S, Dejana E, Dimberg A (agosto 2018). «CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis». The Journal of Clinical Investigation. 128 (8): 3280–3297. PMC 6063507. PMID 29763414. doi:10.1172/JCI97459